Related Experiment Video
Updated: Sep 4, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal
Iris H Liu1, Bian Wu1, Viktoriya Krepkiy1
1Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Francisco, CA.
Insights
Pedal medial arterial calcification (pMAC) predicts persistent ischemia and amputation risk in chronic limb-threatening ischemia (CLTI) patients after revascularization. Higher pMAC scores indicate a greater likelihood of poor outcomes, especially after endovascular treatment.
Area of Science:
- Vascular Surgery
- Radiology
- Cardiovascular Medicine
Background:
- Pedal medial arterial calcification (pMAC) is linked to major amputation in chronic limb-threatening ischemia (CLTI).
- The association between pMAC and amputation may stem from unresolved distal ischemia.
- This study investigates the relationship between pMAC, hemodynamic changes, and amputation risk post-revascularization for CLTI.
Purpose of the Study:
- To investigate the relationships between pedal medial arterial calcification (pMAC) score, hemodynamic changes, and major amputation.
- To determine if pMAC is associated with persistent distal ischemia after infrainguinal revascularization for CLTI.
- To evaluate the influence of pMAC on outcomes following different revascularization techniques (endovascular vs. open bypass).
Main Methods:
- Retrospective study of 306 CLTI patients undergoing infrainguinal revascularization (2011-2020).
- Blinded pMAC scoring (0-5) from foot X-rays; toe pressures measured pre- and post-procedure in 136 patients.
- Ischemia severity assessed using the Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) system.
Main Results:
- Lower pMAC scores correlated with improved hemodynamics (P = .004).
- Failure to improve WIfI ischemia grade was associated with major amputation (P = .0002).
- After endovascular treatment, pMAC 5 independently predicted unimproved ischemia (OR: 4.0) and was associated with major amputation (HR: 15.5).
- After bypass, nonautologous conduit use was the sole predictor of major amputation (HR: 5.6).
Conclusions:
- pMAC score is independently associated with persistent distal ischemia and major amputation after CLTI revascularization.
- pMAC may serve as a marker for hemodynamic response and limb loss risk, particularly after endovascular interventions.
- These findings highlight the prognostic value of pMAC in CLTI management.
Objective:
Pedal medial arterial calcification (pMAC) is associated with major amputation in patients with chronic limb-threatening ischemia (CLTI). We hypothesize that this association would be related to unresolved distal ischemia. We investigated relationships across pMAC score, hemodynamic change, and major amputation after infrainguinal revascularization for CLTI.
Methods:
This is a single-institution, retrospective study of 306 patients who underwent technically successful infrainguinal revascularization for CLTI (2011-2020) and had foot x-rays for blinded pMAC scoring (0-5). A total of 136 (44%) patients had toe pressure measurements performed within 90 days before and 60 days after revascularization. Ischemia grade (0-3) was assigned using the Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) system.
Results:
The revascularization approach was open bypass in 118 (38%) and endovascular in 188 (62%) patients. pMAC scores were trichotomized (0-1 [125; 41%], 2-4 [116; 38%], 5 [65; 21%]). Post-revascularization WIfI ischemia grade was improved in 78 of 136 (57%) and unchanged/worsened in 58 of 136 (43%). A lower pMAC score was associated with hemodynamic improvement (P = .004). Failure to improve the ischemia grade was associated with major amputation (P = .0002). In the endovascular subgroup, WIfI ischemia grade was improved in 43 of 90 (48%) with available measurements, and 37 of 188 (20%) underwent major amputation. In a multivariate logistic model, pMAC 5 was the only factor independently associated with unimproved ischemia grade after endovascular treatment (odds ratio: 4.0 [1.1-16.6], P = .04). In a Cox proportional hazards model, factors independently associated with major amputation after endoluminal revascularization were WIfI stage 4 (hazard ratio [HR]: 2.7 [1.3-5.7], P = .007) and pMAC score (pMAC: 2-4: HR: 10.6 [1.4-80.7], P = .02; pMAC: 5: HR: 15.5 [2.0-119], P = .008). In the bypass subgroup, WIfI ischemia grade was improved in 35 of 46 (76%) with available measurements but was not associated with pMAC score (P = .88) or any other baseline patient or limb characteristics. A total of 19 of 118 (16%) patients underwent major amputation. In a Cox proportional hazards model including bypass conduit, WIfI stage, and pMAC score, the only factor independently associated with major amputation after bypass was use of nonautologous conduit (HR: 5.6 [1.8-17.6], P = .003).
Conclusions:
The pMAC score is independently associated with persistent distal ischemia and major amputation after technically successful revascularization for CLTI. These data suggest that pMAC may be a marker for hemodynamic response to revascularization and risk of limb loss, and it may have a stronger influence on the outcome of endoluminal interventions.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction

